Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33300950

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA
Publication date
2021 Jan 5
First author
Wang X

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA. 2021 Jan 5;325(1):36-38. doi: 10.1001/jama.2020.23371.
    note
    Source null
    related pmid
    33300953
    relationship
    Comment in
  2. citation
    JAMA. 2021 May 4;325(17):1792-1793. doi: 10.1001/jama.2021.2783.
    note
    Source null
    related pmid
    33944880
    relationship
    Comment in
  3. citation
    JAMA. 2021 May 4;325(17):1791-1792. doi: 10.1001/jama.2021.2780.
    note
    Source null
    related pmid
    33944881
    relationship
    Comment in
  4. citation
    JAMA. 2022 May 17;327(19):1929. doi: 10.1001/jama.2022.7048.
    note
    Source null
    related pmid
    35452086
    relationship
    Erratum in

Authors and identifiers

  1. name
    Wang X
    type
    Author
  2. name
    Wang SS
    type
    Author
  3. name
    Huang H
    type
    Author
  4. name
    Cai L
    type
    Author
  5. name
    Zhao L
    type
    Author
  6. name
    Peng RJ
    type
    Author
  7. name
    Lin Y
    type
    Author
  8. name
    Tang J
    type
    Author
  9. name
    Zeng J
    type
    Author
  10. name
    Zhang LH
    type
    Author
  11. name
    Ke YL
    type
    Author
  12. name
    Wang XM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wang X
    type
    Author
  2. name
    Wang SS
    type
    Author
  3. name
    Huang H
    type
    Author
  4. name
    Cai L
    type
    Author
  5. name
    Zhao L
    type
    Author
  6. name
    Peng RJ
    type
    Author
  7. name
    Lin Y
    type
    Author
  8. name
    Tang J
    type
    Author
  9. name
    Zeng J
    type
    Author
  10. name
    Zhang LH
    type
    Author
  11. name
    Ke YL
    type
    Author
  12. name
    Wang XM
    type
    Author
bibliography ids
  1. nci-bib-ff01bfa064f2de9235cb890e
book metadata
content sha256
501c7967b2197dc4a63cee88a027b44965a675c808677b676a42103339f4bf1d
document type
citation
dois
  1. 10.1001/jama.2020.23370
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33300950
immutable id
pubmed:33300950@501c7967b2197dc4a63cee88a027b44965a675c808677b676a42103339f4bf1d
journal
abbreviation
JAMA
issn electronic
1538-3598
issn print
0098-7484
issue
1
name
JAMA
nlm unique id
7501160
pages
50-58
volume
325
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA. 2021 Jan 5;325(1):36-38. doi: 10.1001/jama.2020.23371.
    note
    Source null
    related pmid
    33300953
    relationship
    Comment in
  2. citation
    JAMA. 2021 May 4;325(17):1792-1793. doi: 10.1001/jama.2021.2783.
    note
    Source null
    related pmid
    33944880
    relationship
    Comment in
  3. citation
    JAMA. 2021 May 4;325(17):1791-1792. doi: 10.1001/jama.2021.2780.
    note
    Source null
    related pmid
    33944881
    relationship
    Comment in
  4. citation
    JAMA. 2022 May 17;327(19):1929. doi: 10.1001/jama.2022.7048.
    note
    Source null
    related pmid
    35452086
    relationship
    Erratum in
outcomes validated
false
pmid
33300950
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
feb1c9f66624ea3024599aaf9b56369dd4bd8854aa09aff4315455920cafd019
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2021 Jan 5
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33300950/
title
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.

Preserved source evidence · Not medical advice